Clinical Trial 49566

Brandon, FL 33511


Chronic Obstructive Pulmonary Disease (COPD) - Brandon FL
Click image to enlarge

Researchers at Meris Clinical Research are studying the efficacy, safety, and tolerability of a new investigational drug, when compared with placebo, in treating moderate-to-severe COPD in former smokers.

  • Be 40 to 85 years of age, inclusive
  • Have been diagnosed with moderate-to-severe COPD by a physician for at least 1 year
  • Have a smoking history of ≥10 pack-years
  • Be a former smoker, having stopped smoking 6 or more months ago with the intention to permanently quit
  • Have reported a history of signs and symptoms of chronic bronchitis
  • Have a documented history of high exacerbation risk
  • Have a standard of care controller therapy

*Additional criteria apply to participate. A study coordinator will be able to discuss detailed eligibility with you.

Qualified Participants May Receive:

All qualified participants will have access to an experienced local team of health care professionals and may receive investigational study drug or placebo and study-related care at no cost. Reimbursement for time and travel may be provided if you qualify.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.